Search Results

Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.

• Authors : Chakravarti S; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Kuo CC

• Source: Journal of neuro-oncology [J Neurooncol] 2024 Mar 15. Date of Electronic Publication: 2024 Mar 15.Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma.

• Authors : Schreck KC; Johns Hopkins University School of Medicine, Baltimore, MD, United States.; Strowd RE

• Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.

• Authors : Chakravarti S; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.; Kuo CC

• Source: Journal of neuro-oncology [J Neurooncol] 2024 Mar 04. Date of Electronic Publication: 2024 Mar 04.Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Frontal lobe mass in a 46-year-old woman.

• Authors : Zhang KY; Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.; Ramlal B

Subjects: Glioma* ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging; Female

• Source: Brain pathology (Zurich, Switzerland) [Brain Pathol] 2024 Jan; Vol. 34 (1), pp. e13211. Date of Electronic Publication: 2023 Sep 15.Publisher: International Society of Neuropathology Country of Publication: Switzerland NLM ID: 9216781 Publication Model: Print-Electronic Cited Medium:

Record details

Druggable genomic landscapes of high-grade gliomas.

• Authors : Ghanem P; Johns Hopkins Molecular Tumor Board Investigators

• Source: Frontiers in medicine [Front Med (Lausanne)] 2023 Dec 08; Vol. 10, pp. 1254955. Date of Electronic Publication: 2023 Dec 08 (Print Publication: 2023).Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.

• Authors : Huang Q; Department of Radiology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Department of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA.

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/therapy ; Glioma*/Glioma*/Glioma*/diagnostic imaging

• Source: Magnetic resonance imaging [Magn Reson Imaging] 2023 Oct; Vol. 102, pp. 222-228. Date of Electronic Publication: 2023 Jun 14.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214883 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.

• Authors : Douville C; Department of Oncology, The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA; The Ludwig Center, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA

Subjects: Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/diagnosis ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/genetics ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/cerebrospinal fluid

• Source: Cell reports. Medicine [Cell Rep Med] 2023 Aug 15; Vol. 4 (8), pp. 101148. Date of Electronic Publication: 2023 Aug 07.Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Integrated molecular and clinical analysis of BRAF-mutant glioma in adults.

• Authors : Schreck KC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .

• Source: NPJ precision oncology [NPJ Precis Oncol] 2023 Feb 28; Vol. 7 (1), pp. 23. Date of Electronic Publication: 2023 Feb 28.Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X

Record details

BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report.

• Authors : Munjapara V; aDepartment of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Heumann T

• Source: Case reports in oncology [Case Rep Oncol] 2022 Oct 07; Vol. 15 (3), pp. 909-917. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575

Record details

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.

• Authors : Odeniyide P; Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Yohe ME

Subjects: Rhabdomyosarcoma*/Rhabdomyosarcoma*/Rhabdomyosarcoma*/drug therapy ; Rhabdomyosarcoma*/Rhabdomyosarcoma*/Rhabdomyosarcoma*/genetics ; Rhabdomyosarcoma, Embryonal*

• Source: Oncogene [Oncogene] 2022 May; Vol. 41 (21), pp. 2973-2983. Date of Electronic Publication: 2022 Apr 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details